Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction

Abnormal humoral responses toward motor end plate constituents in muscle induce myasthenia gravis (MG). To study the etiology of this disease, and whether it could be induced by host defense molecules, we examined the consequences of interferon (IFN) gamma production within the neuromuscular junction of transgenic mice. The transgenic mice exhibited gradually increasing muscular weakness, flaccid paralysis, and functional disruption of the neuromuscular junction that was reversed after administration of an inhibitor of acetylcholinesterase, features which are strikingly similar to human MG. Furthermore, histological examination revealed infiltration of mononuclear cells and autoantibody deposition at motor end plates. Immunoprecipitation analysis indicated that a previously unidentified 87-kD target antigen was recognized by sera from transgenic mice and also by sera from the majority of human MG patients studied. These results suggest that expression of IFN-gamma at motor end plates provokes an autoimmune humoral response, similar to human MG, thus linking the expression of this factor with development of this disease.

[1]  N. Sarvetnick,et al.  Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. , 1995, The Journal of clinical investigation.

[2]  P. De Camilli,et al.  Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome , 1993, The Journal of experimental medicine.

[3]  N. Sarvetnick,et al.  Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans , 1993, The Journal of experimental medicine.

[4]  A. Penn,et al.  Cells from Mice Exposed Chronically to D‐Penicillamine Show Proliferative Responses to D‐Penicillamine‐Treated Self (Macrophage/Dendritic Cells): A Graft‐versus‐Host Response? a , 1993, Annals of the New York Academy of Sciences.

[5]  R. Huganir,et al.  The 87K postsynaptic membrane protein from torpedo is a protein-tyrosine kinase substrate homologous to dystrophin , 1993, Neuron.

[6]  H. Oosterhuis,et al.  Myasthenia gravis and myasthenic syndromes. , 1992, Current opinion in neurology and neurosurgery.

[7]  M. Huberman,et al.  Interferon system and natural killer cell activity in myasthenia gravis , 1991, Journal of Neuroimmunology.

[8]  J. Sanes,et al.  Selective expression of an acetylcholine receptor-lacZ transgene in synaptic nuclei of adult muscle fibers. , 1991, Development.

[9]  D. Richman,et al.  Inflammation at the neuromuscular junction in myasthenia gravis , 1991, Neurology.

[10]  J. Martinou,et al.  Nerve-dependent modulation of acetylcholine receptor epsilon-subunit gene expression , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.

[12]  N. Sarvetnick,et al.  Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ , 1990, Nature.

[13]  F. Kantor,et al.  A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in ‘antibody-negative’ myasthenia gravis , 1990, Journal of Neuroimmunology.

[14]  P. De Camilli,et al.  Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. , 1990, The New England journal of medicine.

[15]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.

[16]  G. Fischbach,et al.  A novel 87,000-Mr protein associated with acetylcholine receptors in Torpedo electric organ and vertebrate skeletal muscle , 1989, The Journal of cell biology.

[17]  P. Whiting,et al.  A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671 , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  N. Sarvetnick,et al.  Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma , 1988, Cell.

[19]  M. Schluep,et al.  Immunological Heterogeneity and Cellular Mechanisms in Myasthenia Gravis a , 1987, Annals of the New York Academy of Sciences.

[20]  A. Pestronk,et al.  Humoral Pathogenesis of Myasthenia Grayis a , 1987, Annals of the New York Academy of Sciences.

[21]  A. Vincent,et al.  MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITY , 1986, The Lancet.

[22]  R. Fujinami,et al.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.

[23]  G. Trinchieri,et al.  Immune interferon: a pleiotropic lymphokine with multiple effects. , 1985, Immunology today.

[24]  J. Wolinsky,et al.  Attempts to implicate viruses in myasthenia gravis , 1985, Neurology.

[25]  M. Feldmann,et al.  ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY , 1983, The Lancet.

[26]  F. Kantor,et al.  Nerve stimulation test in murine experimental autoimmune myasthenia gravis , 1982, Annals of neurology.

[27]  S. Heinemann,et al.  FACTORS AFFECTING THE SUSCEPTIBILITY OF DIFFERENT STRAINS OF MICE TO EXPERIMENTAL MY ASTHENIA GRAVIS * , 1981, Annals of the New York Academy of Sciences.

[28]  A. Vincent,et al.  Anti-acetylcholine receptor antibodies. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[29]  J. Lindstrom,et al.  Biology of myasthenia gravis. , 1980, Annual review of pharmacology and toxicology.

[30]  J. Lindstrom,et al.  Antibody to acetylcholine receptor in myasthenia gravis , 1976, Neurology.

[31]  S. Fuchs,et al.  Strain differences in the autoimmune response of mice to acetylcholine receptors , 1976, Nature.

[32]  D. Granato,et al.  Experimental myasthenia in Balb/c mice immunized with rat acetylcholine receptor from rat denervated muscle. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Engel,et al.  THE MOTOR END PLATE IN MYASTHENIA GRAVIS AND IN EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS. A QUANTITATIVE ULTRASTRUCTURAL STUDY * , 1976, Annals of the New York Academy of Sciences.

[34]  I. Silman,et al.  Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor , 1975, Nature.

[35]  J. Lindstrom,et al.  Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs , 1975, The Journal of experimental medicine.

[36]  D. Elmqvist Myasthenia Gravis , 1975, The Lancet.

[37]  D. Drachman,et al.  Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors , 1973, Science.

[38]  J. Patrick,et al.  Autoimmune Response to Acetylcholine Receptor , 1973, Science.

[39]  A. Engel,et al.  Histometric study of neuromuscular junction ultrastructure , 1972, Neurology.

[40]  W. W. Hofmann,et al.  Experimental myasthenia gravis. , 1971, Research publications - Association for Research in Nervous and Mental Disease.

[41]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[42]  J. Simpson,et al.  Experimental myasthenia gravis. , 1969, Lancet.

[43]  J. Desmedt Nature of the Defect of Neuromuscular Transmission in Myasthenic Patients : ‘Post-tetanic Exhaustion’ , 1957, Nature.